Equities
Health CareHealth Care Equipment & Services
  • Price (GBX)1,238.00
  • Today's Change-14.00 / -1.12%
  • Shares traded2.23m
  • 1 Year change10.34%
  • Beta0.5293
Data delayed at least 20 minutes, as of Sep 29 2016 17:12 BST.
More ▼

Key statistics

On Thursday, Smith & Nephew PLC (SN.:LSE) closed at 1,238.00, -6.50% below its 52-week high of 1,324.00, set on Jul 11, 2016.
52-week range
Today
1,040.36Feb 09 20161,324.00Jul 11 2016
Markit short selling activity
Low
Med
High
Open1,253.00
High1,258.00
Low1,233.00
Bid1,232.00
Offer1,262.00
Previous close1,252.00
Average volume2.86m
Shares outstanding887.16m
Free float881.12m
P/E (TTM)40.48
Market cap10.98bn GBP
EPS (TTM)0.3058 GBP
Annual div (IAD)22.40 GBX
Annual div yield (IAD)1.79%
Div ex-dateApr 21 2016
Div pay-dateMay 11 2016
Next div ex-dateOct 06 2016
Next div pay-dateOct 25 2016
Data delayed at least 20 minutes, as of Sep 29 2016 17:12 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Smith & Nephew PLC shares was Hold at 1,245.00 on 02 Aug 2016Read the full article
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.